Ascendis Pharma A/s Earnings

Ascendis Pharma A/s’s revenue jumped 339.04% since last year same period to $158.04Mn in the Q2 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 56.55% jump in its revenue since last 3-months.

Ascendis Pharma A/s’s net profit jumped 64.48% since last year same period to $-38.85Mn in the Q2 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 58.94% jump in its net profits since last 3-months.

Ascendis Pharma A/s’s net profit margin jumped 91.91% since last year same period to -24.58% in the Q2 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 73.77% jump in its net profit margins since last 3-months.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a 77.78% jump from last quarter’s estimates.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current year stand at -0.28.

Ascendis Pharma A/s’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Ascendis Pharma A/s has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.